Skip to main content

Two invest further into ADCs

31st October 2024

Submitted by:

Andrew Warmington

Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic. This has come on the back of growing interest in this modality in the treatment of cancer, which has been forecast to grow at 15%/year to 2028.

Merck KGaA is to spend €70 million to triple capacity at its Bioconjugation Centre of Excellence facility in St. Louis. It will add 3,200 m2 more space for process and analytical development, QC, R&D, manufacturing and logistic, plus a dedicated buffer preparation facility, and a cold storage and a GMP-controlled room temperature warehouse close to the existing facility.

This follows on from the opening of a €59 million, 6500 m2 facility in Verona, Wisconsin, dedicated to doubling production of the most highly potent APIs, in 2022, and other technology innovations in the field. Merck, which is known as EMD in the US, was the first CDMO to be approved for ADC manufacture in the US.

Meanwhile, Sterling Pharma Solutions has announced that it will invest £10 million to more than double GMP bioconjugation capacity for ADCs in a 215 m2 suite with reactors of up to 500L in volume at its site in Deeside, UK (pictured). There will also be a 130 m2 Grade C cleanroom for manufacturing using flexible and hard containment technologies to handle highly potent molecules with exposure limits down to 0.01 µg/m3.

Processing will take place within flexible, single-use bioreactors to increase efficiency and eliminate the potential for cross-contamination between campaigns, with integrated automated transfer and control systems to reduce the need for manual operations, the company added, while stability chamber capacity for the storage and monitoring of final products will be upgraded. This should be complete in early 2026.

Helm, CAC Nantong expand partnership

Helm has reached an agreement with CAC Nantong Chemical to expand their global partnership. Under

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Sterling suite

CDMOs grow in ADCs

Reflecting the ongoing boom in the development antibody-drug conjugates (ADCs), two Western CDMOs announced expansions

Submitted by:

Andrew Warmington

Flamma Lundbeck

Flamma buys Lundbeck site

Italian CDMO Flamma has entered into an agreement to acquire Lundbeck Pharmaceuticals Italy (LuPI) from

Submitted by:

Andrew Warmington

Opening ceremony at UPM's biorefinery in Leuna

UPM opens biorefinery in Germany

UPM has inaugurated a biorefinery in Leuna, Germany, which will make up to 220,000 tonnes/year

Submitted by:

Andrew Warmington

Solenis pulp centre in Brazil

Solenis moves pulp centre

Solenis has relocated its Pulp Centre of Excellence from the US to a new facility

Submitted by:

Andrew Warmington

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Symrise facility in India

Symrise in double Asian expansion

Symrise has announced that it has opened its new Scent Creative Centre in Singapore and

Submitted by:

Andrew Warmington

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

Semiconductor manufacturing

Sumitomo Chemical works with Tata

Sumitomo Chemical has signed a Memorandum of Understanding with India’s Tata Electronics to explore a

Submitted by:

Andrew Warmington

FramoChem and VanDeMark are separated

VanDeMark separation is complete

Japan’s Hodogaya Chemical has completed the previously announced acquisition of Hungarian API and intermediates producer

Submitted by:

Andrew Warmington